Company

Neurotech Pharmaceuticals, Inc.

Neurotech Pharmaceuticals develops therapies for chronic eye diseases using its Encapsulated Cell Therapy platform.

About

Neurotech Pharmaceuticals develops therapies for chronic eye diseases using its Encapsulated Cell Therapy platform, including a treatment designed to release CNTF to protect retinal photoreceptors. The company is based in Lincolnshire, US, and Rich Small is CEO. It raised USD 5.05 million in a Series F round on April 30, 2014, from Versant Ventures and other investors.

3Funding rounds

16Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in